Inflammation Driven by Overexpression of the Hypoglycosylated Abnormal Mucin 1 (MUC1) Links Inflammatory Bowel Disease and Pancreatitis
- 1 May 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pancreas
- Vol. 39 (4), 510-515
- https://doi.org/10.1097/mpa.0b013e3181bd6501
Abstract
Objective: Pancreatitis occurs as an extraintestinal complication of inflammatory bowel disease (IBD), but the cause is poorly understood. Mucin 1 (MUC1) is overexpressed in an abnormal, hypoglycosylated form on the colonic epithelium in human IBD where it contributes to inflammation. MUC1 is also expressed on pancreatic ductal epithelia. We tested the possibility that in IBD, MUC1 expression on pancreatic ducts is also abnormal leading to inflammation and pancreatitis. Methods: We used MUC1+/interleukin-10−/− mice that develop IBD. We imaged abnormal MUC1 expression in these mice by adoptively transferring T cells from T cell receptor transgenic mice specific for abnormal MUC1. Cells were labeled with a novel perfluorocarbon tracer reagent and quantified and visualized in vivo using high-throughput 19F nuclear magnetic resonance spectroscopy and magnetic resonance imaging. Results: MUC1-specific T cells migrated to the colon in mice with IBD and also to the pancreas. Immunohistochemistry confirmed increased expression on the pancreatic ducts of the abnormal MUC1 seen in the colon and the presence of cellular infiltrate. Conclusions: Migration of MUC1-specific T cells to the colon and the pancreas in diseased mice suggests that pancreatitis is an extraintestinal site of IBD, characterized by proinflammatory abnormal expression of MUC1. Therapies directed against abnormal MUC1 have the potential of targeting the disease in both sites.Keywords
This publication has 32 references indexed in Scilit:
- Fluorine‐19 MRI for visualization and quantification of cell migration in a diabetes modelMagnetic Resonance in Medicine, 2007
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Alterations in the Composition of the Supramucosal Defense Barrier in Relation to Disease Severity of Ulcerative ColitisJournal of Histochemistry & Cytochemistry, 2006
- Recognition of tumor glycans by antigen-presenting cellsCurrent Opinion in Immunology, 2006
- MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-CateninCancer Research, 2005
- The MUC1 Oncoprotein Activates the Anti-apoptotic Phosphoinositide 3-Kinase/Akt and Bcl-xL Pathways in Rat 3Y1 FibroblastsJournal of Biological Chemistry, 2004
- MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasionOncogene, 2003
- The Dichotomy in the Preinvasive Neoplasia to Invasive Carcinoma Sequence in the Pancreas: Differential Expression of MUC1 and MUC2 Supports the Existence of Two Separate Pathways of CarcinogenesisLaboratory Investigation, 2002
- Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon‐γ and tumor necrosis factor‐αJournal of Cellular Biochemistry, 2002
- Interleukin-10-deficient mice develop chronic enterocolitisCell, 1993